Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First-line Treatment of Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07226856
What this trial is testing

BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Mayo Clinic 43
Testing effectiveness (Phase 2)UnknownNCT03636308
What this trial is testing

Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Peking University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05218889
What this trial is testing

Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerPDAC - Pancreatic Ductal AdenocarcinomaPancreas Cancer+1 more
Chinese PLA General Hospital 90
Testing effectiveness (Phase 2)Study completedNCT00085371
What this trial is testing

Triapine as First-Line or Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasRecurrent Pancreatic Cancer+2 more
National Cancer Institute (NCI) 116
Testing effectiveness (Phase 2)Study completedNCT02351219
What this trial is testing

FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma Stage III
Azienda Ospedaliero, Universitaria Pisana 50
Testing effectiveness (Phase 2)Study completedNCT04662112
What this trial is testing

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Asan Medical Center 40
Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00226005
What this trial is testing

PTK787 in Patients With Advanced Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Neoplasm
Pancreatic Cancer Research Team 67
Early research (Phase 1)Not Yet RecruitingNCT07348107
What this trial is testing

ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Daniel Breadner 10
Large-scale testing (Phase 3)Study completedNCT03766295
What this trial is testing

Masitinib Plus Gemcitabine in Pancreatic Cancer

Who this might be right for
Locally Advanced or Metastatic Pancreatic Cancer
AB Science 377
Large-scale testing (Phase 3)Looking for participantsNCT05653453
What this trial is testing

Clinical Study of Tumor Treating Fields Combined with Gemcitabine and Albumin-bound Paclitaxel in the First-line Treatment of Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Cancer
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 512
Testing effectiveness (Phase 2)Looking for participantsNCT06333314
What this trial is testing

Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI

Who this might be right for
Pancreatic AdenocarcinomaAmpulla of Vater CarcinomaAdrenocortical Carcinoma+5 more
UNICANCER 120
Testing effectiveness (Phase 2)Study completedNCT00673504
What this trial is testing

First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Central European Society for Anticancer Drug Research 105
Testing effectiveness (Phase 2)Study completedNCT06266143
What this trial is testing

A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic Adenocarcinoma
Wuhan YZY Biopharma Co., Ltd. 71
Testing effectiveness (Phase 2)Study completedNCT00372944
What this trial is testing

AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine Therapy

Who this might be right for
Pancreatic Cancer
AstraZeneca 70